Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
PaperCitations, authors & open-access status
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 213 citations, 2021 year and hybrid oa status.
213
Citations
2021
Year
hybrid
OA Status